Select Medical Holdings (SEM) Revenue (2018 - 2026)

Select Medical Holdings has disclosed Revenue across 9 years of filings, most recently posting $1.4 billion for Q1 2026.

• In Q1 2026, Revenue rose 5.05% year-over-year to $1.4 billion; the TTM figure through Mar 2026 stood at $5.5 billion (up 5.79% YoY), while the FY2025 annual figure was $5.5 billion, up 5.12% from the prior year.
• Revenue improved to $1.4 billion in Q1 2026, from $1.4 billion in the prior quarter.
• Over the last five years, Revenue for SEM reached as high as $1.6 billion in Q1 2022 and fell as low as -$142.9 million in Q4 2022.
• The 5-year median for Revenue is $1.3 billion (2024), against an average of $1.3 billion.
• Annual changes were most pronounced in 2022 — Revenue sank 109.16% — and 2023, when it surged 952.41%.
• A 5-year view of Revenue shows it stood at -$142.9 million in 2022, then surged by 952.41% to $1.2 billion in 2023, then grew by 7.75% to $1.3 billion in 2024, then advanced by 6.41% to $1.4 billion in 2025, then rose by 1.78% to $1.4 billion in 2026.
• According to Business Quant data, Revenue over the past three periods registered $1.4 billion, $1.4 billion, and $1.4 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.